FARMINGDALE, N.Y.--(BUSINESS WIRE)--Misonix, Inc. (Nasdaq: MSON), a developer of minimally invasive ultrasonic medical device technology for the treatment of cancer and other chronic health conditions, today announced that it had retained the services of Cameron Associates, Inc., a leading investor relations and strategic advisory firm, to assist in the Company's shareholder communications program. Cameron Associates, founded in 1976, is a New York-based, full-service investor relations firm that currently advises over 40 public companies in the areas of investor relations, public relations, and corporate governance.
